Sirs, Nephronophthisis (NPHP) is an autosomal recessive cystic kidney disease that constitutes the most frequent genetic cause for end-stage renal disease (ESRD) in the first three decades of life. Homozygous deletions in the NPHP1 gene account for approximately 21% of all NPHP cases, whereas other genes contribute less than 3% each. Interestingly, positional cloning of the nine known NPHP genes (NPHP 1-9) and functional characterization of their encoded proteins (nephrocystins) have contributed to a unifying theory that defines cystic kidney diseases as "ciliopathies" [1] .
Clinical and molecular data on NPHP in Egyptian children are currently lacking. We have therefore investigated the prevalence of the homozygous NPHP1 deletion among a cohort of children with a presumptive diagnosis of NPHP at the Center of Pediatric Nephrology and Transplantation (CPNT), Cairo University.
The patient cohort comprised 20 children from 17 independent families who met the clinical and ultrasonographic criteria of NPHP. All patients had an ophthalmologic examination, and magnetic resonance imaging (MRI) of the brain was carried out in children with neurological involvement. Analysis for a homozygous deletion of the NPHP1 gene was performed employing a multiplex PCR approach on the genomic DNA of patients, as described earlier [2] . Sex distribution among the affected patients showed a slight preponderance of females (1.2:1, 11 females and 9 males). Seventy-five percent of our study patients were the products of consanguineous marriages, the percentage of affected siblings was strikingly high (65%, 13/20 patients), and 40% (8/20 patients) had a history of sibling death due to a similar condition.
Among the 20 patients, 15 (75%) presented with signs of ESRD. All patients suffered from anemia and growth retardation when they first presented for medical attention. Nineteen of the patients (95%) had a history typical of nephronophthisis, with symptoms of polydipsia, polyuria, and secondary enuresis. Four of the patients (20%) were hypertensive, with elevated blood pressure above the 95th percentile for age, gender, and height.
Clinically, the patients were best categorized as presenting with isolated juvenile NPHP (65%, 13/20) and infantile NPHP (15%, 3/20). The remaining four patients (20%) had extrarenal associations (molar tooth sign on brain MRI, ataxia, mental retardation, retinal dystrophy, oculomotor apraxia, and facial dysmorphy) and hence were clinically categorized as Joubert Syndrome Related Disorder (JSRD). The mean age at diagnosis was 87.5±45.4 months, which was significantly late compared to the age of onset of symptoms (43.8±29.7 months) (P<0.01).
Homozygous deletions in the NPHP1 gene were identified in six patients from five independent families of the 17 families studied (29.4%), thereby confirming the diagnosis of type 1 nephronophthisis (Fig. 1) . This does not seem to differ from the figures reported in Western countries. Five patients had isolated NPHP, whereas the sixth patient was among the JSRD group, with distinct molar tooth sign detected on his brain MRI images, ataxia, retinitis pigmentosa, and dysmorphic facies. These findings confirm that NPHP1 deletions can indeed be responsible for JSRD, as previously reported [3] .
We also report one patient with the homozygous NPHP1 deletion presenting with an infantile onset phenotype. It has been reported in the literature that infantile NPHP, which is frequently caused by mutations in the NPHP2/inversin gene, differs from other types of NPHP in the early age of onset of ESRD, usually at age <5 years in all reported cases, whereas the median age of ESRD in juvenile NPHP (NPHP type 1 or type 4) is about 13 years [4] . Renal cortical microcysts is another criterion, with detailed analysis of a murine model of NPHP2/inversin demonstrating cystic dilatation of Bowman's capsule, proximal tubule, and thick ascending limb and collecting duct [5] .
Although homozygous NPHP1 deletion is the most frequent NPHP1 mutation known, in more than 6% of all NPHP1 cases, the underlying mutation has been found to be a heterozygous deletion combined with a single point mutation [2] . In a future study, we are planning to investigate patients with no homozygous NPHP1 deletion for the presence of heterozygous deletions. Further analysis of all other NPHP loci for potential homozygosity in consanguineous families and the sequencing of all exons of NPHP genes located within regions of significant homozygosity are crucial for the identification of the underlying genetic defect.
Our infantile NPHP patient showed most of the clinical and histopathological features of NPHP type 2 [4] : (1) characteristic cortical cysts in normal-sized hyperechogenic kidneys on renal sonogram; (2) distinct renal microcysts in the kidney, revealed by histopathological examination; (3) clinical manifestations that began in the first year of life and progressed to ESRD by the age of 32 months. In conclusion, the prevalence of homozygous deletions in the NPHP1 gene does not seem to differ in Egypt from that reported in Western countries. To the best of our knowledge, this is the first report of a homozygous NPHP1 deletion in an infantile-onset NPHP patient. Fragments were separated on a 1.5% agarose gel for 3 h at 120 V. Note that patients of lanes 7, 8, 13-16 lack the bands for the respective NPHP1 exons, indicating a homozygous NPHP1 deletion and confirming the diagnosis NPHP type 1. White bars Sibling cases. Lane M 100-bp ladder DNA size marker (New England Biolabs, Beverly, MA)
